Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Objectives: To date, there is no single medication prescribed to alleviate all the core symptoms of Autism Spectrum Disorder (ASD; National Institute of Health and Care Excellence, 2016). Both serotonin reuptake inhibitors and drugs for psychosis possess therapeutic drawbacks when managing anxiety and aggression in ASD. This review sought to appraise the use of propranolol as a pharmacological alternative when managing emotional, behavioural and autonomic dysregulation (EBAD) and other symptoms. Materials and methods: Sixteen reports examined the administration of propranolol in the context of ASD. Results: Sixteen reports broadly covered cognitive domains, neural correlates, and behavioural domains. From the eight single-dose clinical trials, propranolol led to significant improvements in cognitive performance – verbal problem solving, social skills, mouth fixation, and conversation reciprocity; and changes in neural correlates – improvement in semantic networks and functional connectivity. The remaining eight case series and single case reports showed improvements in EBAD, anxiety, aggressive, self-injurious and hypersexual behaviours. Additionally, propranolol significantly improved similar behavioural domains (aggression and self-injury) for those with acquired brain injury. Conclusion: This review indicates that propranolol holds promise for EBAD and cognitive performance in ASD. Given the lack of good quality clinical trials, randomised controlled trials are warranted to explore the efficacy of propranolol in managing EBAD in ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179964f · Cited by 3,399 · cited 1×
“Among others, concerning behaviours that commonly occur in ASD include aggression, anxiety, phobias, hyperactivity, compulsive behaviour, depression, suicidal ideation or attempted suicide and sleep disorders (Brereton et al., 2006; Cassidy et al., 2014; Simonoff et al., 2008; Stewart et al., 2006).”
BackgroundAnxiety Disorders in Children and Adolescents with Autistic Spectrum Disorders: A Meta-Analysis
van Steensel, F. J. A., Bögels, S. M., & Perrin, S. (2011) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-011-0097-0 · Cited by 1,463 · cited 1×
“Other studies suggest that anxiety disorders and/or heightened aggression occur in 40% and 56% of children and adolescents with ASD, respectively (Kanne and Mazurek, 2011; van Steensel et al., 2011).”
BackgroundAnxiety in children and adolescents with autism spectrum disorders
White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.003 · Cited by 1,427 · cited 1×
“Anxiety disorders frequently present in children and adolescents with ASD, with comorbidity ranges of 40–84% for any anxiety disorder, 8–63% for specific phobias, 5–23% for generalised anxiety, 13–29% for social anxiety and 8–27% for separation anxiety (White et al, 2009; Sukhodolsky, 2013).”
BackgroundThe impact of behaviour problems on caregiver stress in young people with autism spectrum disorders
Lecavalier, L., Leone, S., & Wiltz, J. (2006) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2005.00732.x · Cited by 1,163 · cited 1×
“ASD is associated with long-term psychosocial impairment (Billstedt et al., 2005) and substantial burden on the individual, their family and caregivers, in addition to social and economic burden (Knapp et al., 2009; Lecavalier et al., 2006).”
BackgroundBrain structural abnormalities in young children with autism spectrum disorder
Sparks, B. F., Friedman, S. D., Shaw, D. W., Aylward, E. H., Echelard, D., Artru, A. A., Maravilla, K. R., Giedd, J. N., Munson, J., Dawson, G., et al. (2002) · Neurology · doi:10.1212/wnl.59.2.184 · Cited by 961 · cited 1×
“This provides further support for the use of propranolol, as both ABI and ASD present with neurological difficulties (Sparks et al., 2002).”
Prevalence of autism-spectrum conditions: UK school-based population study
Baron-Cohen, S., Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E., & Brayne, C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.059345 · Cited by 918
Billstedt, E., Gillberg, C., & Gillberg, C. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-3302-5 · Cited by 783 · cited 1×
“ASD is associated with long-term psychosocial impairment (Billstedt et al., 2005) and substantial burden on the individual, their family and caregivers, in addition to social and economic burden (Knapp et al., 2009; Lecavalier et al., 2006).”
BackgroundAggression in Children and Adolescents with ASD: Prevalence and Risk Factors
Kanne, S. M., & Mazurek, M. O. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1118-4 · Cited by 533 · cited 1×
“Other studies suggest that anxiety disorders and/or heightened aggression occur in 40% and 56% of children and adolescents with ASD, respectively (Kanne and Mazurek, 2011; van Steensel et al., 2011).”
BackgroundCohen, J. D., Braver, T. S., & O´Reilly, R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0138 · Cited by 487 · cited 1×
“Executive functioning was measured via the AX-CPT task (Carter et al., 1998; Cohen et al., 1996) where a target button was to be pressed when they saw a cue letter ‘X’ that immediately follows a probe letter ‘A’, and for other stimuli they pressed a non-target button.”
MethodBeta cell hubs dictate pancreatic islet responses to glucose
Johnston, N. R., Mitchell, R. K., Haythorne, E., Pessoa, M. P., Semplici, F., Ferrer, J., Piemonti, L., Marchetti, P., Bugliani, M., Bosco, D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.020 · Cited by 454 · cited 2×
“When utilising propranolol within this patient group it is important to consider that propranolol can impact the synthesis and secretion of insulin, leading to a greater risk of developing diabetes and other metabolic syndromes (Bangalore et al., 2007; Johnston et al., 2016).”
BackgroundMethod
Cited by
Emotional Dysregulation in Children and Adolescents With Psychiatric Disorders. A Narrative Review
Paulus, F. W., Ohmann, S., Möhler, E., Plener, P., & Popow, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.628252 · Cited by 280
The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders
Casanova, E. L., Baeza-Velasco, C., Buchanan, C. B., & Casanova, M. F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040260 · Cited by 109
Theriault (n.d.) · doi:10.31234/osf.io/pkzr8 · Cited by 51
Dell’Osso, L., Massoni, L., Battaglini, S., Cremone, I. M., Carmassi, C., & Carpita, B. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00390-6 · Cited by 48
Szeleszczuk, Ł., & Frączkowski, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710099 · Cited by 46
Metadata
- Authors
- Sagar-Ouriaghli, I., Lievesley, K., & Santosh, P. J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2018-02-27
- Volume
- 32
- Issue
- 6
- Pages
- 641-653
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2792611922
- Cited by
- 56
- References
- 22
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. https://app.cochat.ai/papers/10.1177/0269881118756245
- The paper
- Sagar-Ouriaghli, I., Lievesley, K., & Santosh, P. J. (2018). Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. Journal of Psychopharmacology. https://doi.org/10.1177/0269881118756245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.